Medicofarma Biotech (WAR:MDB) Cyclically Adjusted Book per Share: zł0.17 (As of Mar. 2026)


WAR:MDB Medicofarma Biotech SA WAR:MDB
33 GF Score
Price zł0.43
GF Value zł0.05
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medicofarma Biotech Cyclically Adjusted Book per Share?

Medicofarma Biotech WAR:MDB -0.46% 33 Cyclically Adjusted Book per Share is zł0.17 as of Mar. 2026. GuruFocus rates WAR:MDB with a GF Score™ of 33/100 and a GF Value™ of zł0.05 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medicofarma Biotech's adjusted book value per share for the three months ended in Mar. 2026 was zł0.075. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł0.17 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medicofarma Biotech's average Cyclically Adjusted Book Growth Rate was -5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Medicofarma Biotech was 6.30% per year. The lowest was 0.00% per year. And the median was 3.15% per year.

As of today (2026-07-02), Medicofarma Biotech's current stock price is zł0.434. Medicofarma Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was zł0.17. Medicofarma Biotech's Cyclically Adjusted PB Ratio of today is 2.55.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medicofarma Biotech was 13.47. The lowest was 1.42. And the median was 5.28.


Medicofarma Biotech  (WAR:MDB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medicofarma Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.434/0.17
=2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medicofarma Biotech was 13.47. The lowest was 1.42. And the median was 5.28.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medicofarma Biotech Cyclically Adjusted Book per Share Related Terms


Medicofarma Biotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Medicofarma Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicofarma Biotech Cyclically Adjusted Book per Share Chart

Medicofarma Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.17 0.18 0.18 0.17

Medicofarma Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.17 0.17 0.17 0.17

WAR:MDB vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicofarma Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicofarma Biotech Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicofarma Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medicofarma Biotech's Cyclically Adjusted PB Ratio falls into.


WAR:MDB
33GF Score
Medicofarma Biotech SA WAR:MDB
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicofarma Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicofarma Biotech's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.075/163.0700*163.0700
=0.075

Current CPI (Mar. 2026) = 163.0700.

Medicofarma Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.118 99.552 0.193
201609 0.116 99.064 0.191
201612 0.136 100.366 0.221
201703 0.130 101.018 0.210
201706 0.124 101.180 0.200
201709 0.126 101.343 0.203
201712 0.144 102.564 0.229
201803 0.139 102.564 0.221
201806 0.135 103.378 0.213
201809 0.136 103.378 0.215
201812 0.152 103.785 0.239
201903 0.140 104.274 0.219
201906 0.127 105.983 0.195
201909 0.110 105.983 0.169
201912 0.101 107.123 0.154
202003 0.083 109.076 0.124
202006 0.070 109.402 0.104
202009 0.056 109.320 0.084
202012 -0.034 109.565 -0.051
202103 -0.002 112.658 -0.003
202106 0.218 113.960 0.312
202109 0.218 115.588 0.308
202112 0.209 119.088 0.286
202203 0.202 125.031 0.263
202206 0.190 131.705 0.235
202209 0.179 135.531 0.215
202212 0.186 139.113 0.218
202303 0.177 145.950 0.198
202306 0.168 147.009 0.186
202309 0.162 146.113 0.181
202312 0.135 147.741 0.149
202403 0.146 149.044 0.160
202406 0.128 150.997 0.138
202409 0.115 153.439 0.122
202412 0.101 154.660 0.106
202503 0.090 157.021 0.093
202506 0.081 157.509 0.084
202509 0.070 158.000 0.072
202512 0.084 158.320 0.087
202603 0.075 163.070 0.075

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of zł0.17 mean?
Medicofarma Biotech (WAR:MDB) has a Cyclically Adjusted Book per Share of zł0.17 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medicofarma Biotech and its competitors.
Is Medicofarma Biotech's Cyclically Adjusted Book per Share too high?
Medicofarma Biotech's current Cyclically Adjusted Book per Share is zł0.17. Overall, Medicofarma Biotech has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medicofarma Biotech's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Medicofarma Biotech's Cyclically Adjusted Book per Share of zł0.17 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medicofarma Biotech and its competitors. Medicofarma Biotech's current Cyclically Adjusted Book per Share is zł0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicofarma Biotech stock overvalued right now?
Based on GuruFocus' analysis, Medicofarma Biotech (WAR:MDB) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.05, compared to a current price of zł0.43 — trading 768% above its estimated fair value. The current Cyclically Adjusted Book per Share is zł0.17. Medicofarma Biotech's overall GF Score™ is 33/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Medicofarma Biotech (WAR:MDB), the current Cyclically Adjusted Book per Share is zł0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicofarma Biotech (WAR:MDB) Overvalued in 2026?

Based on GuruFocus' analysis, Medicofarma Biotech stock appears to be overvalued. The current stock price of zł0.43 is trading 768% above its estimated GF Value™ of zł0.05. GuruFocus considers Medicofarma Biotech to be Significantly Overvalued.

Key valuation signals for WAR:MDB:

  • Cyclically Adjusted Book per Share: zł0.17
  • GF Value™: zł0.05 vs. price of zł0.43 (768% above fair value)
  • GF Score™: 33/100 with 6 warning signs

No single metric tells the full story. See the WAR:MDB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicofarma Biotech Business Description

Address ul. Sokołowska 9 lok. U19, Warsaw, POL, 01-142
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.
33GF Score

Get the complete analysis for WAR:MDB

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.43
Price
zł0.05
GF Value